APIX Biosciences
De berekende faillissementskans van APIX Biosciences over 12 maanden bedraagt 1,0% (laag). Het bedrijf is actief sinds 2021 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 4 jaar |
| Bestuur | 4 |
| Vestigingen | 2 |
| Publicaties | 19 |
Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 30-04-2025 | verkort | 28-11-2025 | 2025-00572899 |
| 30-04-2024 | verkort | 29-11-2024 | 2024-00607526 |
| 30-04-2023 | verkort | 22-12-2023 | 2023-00535781 |
| 30-04-2022 | micro | 30-11-2022 | 2022-20528253 |
-
DE LIERRechtspersoonBestuurder· vast vert.: François van LierdeStaatsblad-akte 25147485 (20-11-2025)Actief28-08-2025 → heden
-
Actief28-08-2025 → heden
-
Actief19-06-2025 → heden
-
Actief21-06-2022 → heden
2 gebeurtenissen
- 21-06-2022 Benoemd· Bestuurder
- 21-06-2022 Benoemd· Gedelegeerd bestuurder
Voormalige bestuurders (5)
-
Voormalig19-12-2023 → 25-08-2025
2 gebeurtenissen
- 25-08-2025 Ontslagen· Bestuurder
- 19-12-2023 Benoemd· Bestuurder
-
Voormalig— → 25-08-2025
-
Voormalig— → 19-06-2025
-
Voormalig— → 24-11-2023
-
Voormalig— → 21-06-2022
2 gebeurtenissen
- 21-06-2022 Ontslagen· Bestuurder
- 21-06-2022 Ontslagen· Gedelegeerd bestuurder
| NACE primair | 72101 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 23-07-2021 |
| Status | Actief |
| Postcode | 8750 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 37018C0214/00S002 | Vlaanderen | 2.274 m² | 1 · 2.877 m² | — |
| 37018D0409/00R000 | Vlaanderen | 2.204 m² | 1 · 140 m² | 7,4 m · 2 verd. |
| 37018D0016/00H002 | Vlaanderen | 644 m² | 1 · 362 m² | 12,7 m · 2 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
27-11-2025 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"notary": {
"name": "Benedikt DEBERDT",
"firm_city": null,
"firm_name": "Notaris Benedikt DEBERDT",
"office_city": "Tielt",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-11-27",
"filing_date": "2025-11-25",
"act_kind_objet": "DIVERSEN"
},
"key_dates": [
{
"date": "2025-10-29",
"label": "akte date"
},
{
"date": "2025-11-05",
"label": "Registratierechten"
},
{
"date": "2025-11-27",
"label": "Bijlagen bij het Belgisch Staatsblad"
},
{
"date": "2025-11-25",
"label": "Neergelegd"
}
],
"key_parties": [
{
"kbo": "0771667563",
"kind": "org",
"name": "APIX Biosciences",
"role": "Aandeelhouder"
},
{
"kind": "person",
"name": "Notaris Benedikt DEBERDT",
"role": "Notaris"
},
{
"kind": "org",
"name": "Raad van Bestuur",
"role": "Bestuurder"
}
],
"key_amounts_eur": [
{
"label": "Ontvangen registratierechten",
"amount": 50.0
}
],
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": null
},
"summary_narrative": "",
"co_filed_documents": [],
"detected_real_type": "statutes_change"
}20-11-2025 2 bestuurders benoemd, 2 ontslagnemend
- François van Lierde — Bestuurder
- Maarten Duyck — Bestuurder
- Jeremy Barnes — Bestuurder
- Tina Rogge — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeremy Barnes",
"address": "Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "voluntary",
"subkind": "voluntary",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-08-25",
"evidence_quote": "Het vrijwillig ontslag van de heer Jeremy Barnes, wonende te Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland, als bestuurder met ingang van 25/08/2025",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tina Rogge",
"address": "Sint Barbarastraat 30, 9990 Maldegem, Belgi\u00EB",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "voluntary",
"subkind": "voluntary",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-08-25",
"evidence_quote": "het vrijwillig ontslag van mevrouw Tina Rogge, wonende te Sint Barbarastraat 30, 9990 Maldegem, Belgi\u00EB, als bestuurder met ingang van 25/08/2025",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Fran\u00E7ois van Lierde",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "successor_conditional",
"via_org": {
"kbo": "0776.975.839",
"name": "BV DE LIER",
"address": "8300 Knokke-Heist, Koningin Fabiolalaan 9 bus 11",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "met onmiddellijke ingang de volgende bestuurders te co\u00F6pteren: BV DE LIER, een besloten vennootschap naar Belgisch recht, met zetel te 8300 Knokke-Heist, Koningin Fabiolalaan 9 bus 11 en ingeschreven in de Kruispuntbank voor Ondernemingen onder het nummer 0776.975.839, vast vertegenwoordigd door de ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": "93.12.20-529.35",
"name": "Maarten Duyck",
"address": "1050 Elsene, Gewijde-Boomstraat 87",
"birth_date": "1993-12-20",
"profession": null,
"birth_place": "Jette"
},
"reason": null,
"subkind": "successor_conditional",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "de heer Maarten Duyck, geboren te Jette op 20 december 1993, ingeschreven in het Rijksregister onder nummer 93.12.20-529.35, woonachtig te 1050 Elsene, Gewijde-Boomstraat 87.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-11-20",
"filing_date": "2025-08-28",
"act_kind_objet": "ONTSLAG EN BENOEMING"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2025-08-28",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES NV",
"legal_form": "NV"
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}20-11-2025 2 bestuurders benoemd, 2 ontslagnemend
- François van Lierde — Bestuurder
- Maarten Duyck — Bestuurder
- Jeremy Barnes — Bestuurder
- Tina Rogge — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeremy Barnes",
"address": null,
"birth_date": null
},
"effective_date": "2025-08-25",
"evidence_quote": "Het vrijwillig ontslag van de heer Jeremy Barnes, wonende te Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland, als bestuurder met ingang van 25/08/2025"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tina Rogge",
"address": null,
"birth_date": null
},
"effective_date": "2025-08-25",
"evidence_quote": "het vrijwillig ontslag van mevrouw Tina Rogge, wonende te Sint Barbarastraat 30, 9990 Maldegem, Belgi\u00EB, als bestuurder met ingang van 25/08/2025."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Fran\u00E7ois van Lierde",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0776975839",
"name": "BV DE LIER",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-08-28",
"evidence_quote": "BV DE LIER, een besloten vennootschap naar Belgisch recht, met zetel te 8300 Knokke-Heist, Koningin Fabiolalaan 9 bus 11 en ingeschreven in de Kruispuntbank voor Ondernemingen onder het nummer 0776.975.839, vast vertegenwoordigd door de heer Fran\u00E7ois van Lierde"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Maarten Duyck",
"address": null,
"birth_date": null
},
"effective_date": "2025-08-28",
"evidence_quote": "de heer Maarten Duyck, geboren te Jette op 20 december 1993, ingeschreven in het Rijksregister onder nummer 93.12.20-529.35, woonachtig te 1050 Elsene, Gewijde-Boomstraat 87."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}18-07-2025 1 bestuurder benoemd, 1 ontslagnemend
- BOGAERT Thierry — Bestuurder
- BOGAERT Thierry — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BOGAERT Thierry",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-19",
"evidence_quote": "De vergadering besluit tot het ontslag als bestuurder van de heer BOGAERT Thierry, voornoemd, en dit met ingang vanaf heden. Kwijting wordt hem verleend op de eerstvolgende algemene vergadering."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BOGAERT Thierry",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0771404277",
"name": "Mellona",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-19",
"evidence_quote": "Wordt aangesteld als bestuurder en dit met ingang vanaf heden, \u201CMellona\u201D, maatschap voornoemd, vast vertegenwoordigd door de heer BOGAERT Thierry, voornoemd, die zijn mandaat heeft aanvaard, en dit tot en met 22 juli 2027."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}18-07-2025 1 bestuurder benoemd, 1 ontslagnemend
- BOGAERT Thierry — Bestuurder
- BOGAERT Thierry — Bestuurder
Technische details
{
"events": [
{
"kind": "decharge_granted",
"role": "voorzitter",
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De algemene vergadering ontslaat de voorzitter lezing te geven van het bijzonder verslag van de raad van bestuur en van de externe bedrijfsrevisor omtrent navermelde (onevenredige) uitgifte van nieuwe aandelen van de vennootschap in het kader van de navermelde kapitaalverhoging in geld aangezien all",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BOGAERT Thierry",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering besluit tot het ontslag als bestuurder van de heer BOGAERT Thierry, voornoemd, en dit met ingang vanaf heden.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BOGAERT Thierry",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0771.404.277",
"name": "Mellona",
"address": null,
"country": null,
"legal_form": "maatschap"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "Wordt aangesteld als bestuurder en dit met ingang vanaf heden, \u201CMellona\u201D, maatschap voornoemd, vast vertegenwoordigd door de heer BOGAERT Thierry, voornoemd, die zijn mandaat heeft aanvaard, en dit tot en met 22 juli 2027.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_pending",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BOGAERT Thierry",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Kwijting wordt hem verleend op de eerstvolgende algemene vergadering.",
"decharge_status": "pending_next_agm",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Benedikt DEBERDT",
"firm_city": null,
"firm_name": "Notaris Benedikt DEBERDT",
"office_city": "Tielt",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-18",
"filing_date": "2025-07-16",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-06-19",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Benedikt DEBERDT",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"co\u00F6rdinatie van de statuten",
"verslag van de raad van bestuur",
"verslag van de bedrijfsrevisor"
],
"corrected_publication_numac": null
}18-07-2025 Kapitaalverhoging van €22.189.403,04 tot €28.616.682,67
- €6.427.279,63 → €28.616.682,67
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 28616682.67,
"delta_eur": 22189403.04,
"before_eur": 6427279.63,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 14081,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1575.84
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 22189403.04,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Benedikt DEBERDT",
"firm_city": null,
"firm_name": "Notaris Benedikt DEBERDT",
"office_city": "Tielt",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-18",
"filing_date": "2025-07-16",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-19",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"co\u00F6rdinatie van de statuten",
"verslag van de raad van bestuur",
"verslag van de bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 14046,
"class_name": "Preferente Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 35,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}18-07-2025 Kapitaalverhoging van €22.189.403,04 tot €28.616.682,67
- €6.427.279,63 → €28.616.682,67
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 22189403.04,
"currency": "EUR",
"after_eur": 28616682.67,
"delta_eur": 22189403.04,
"before_eur": 6427279.63,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-06-19",
"evidence_quote": "De vergadering beslist een kapitaalverhoging door te voeren ten bedrage van 22.189.403,04 EUR, om het kapitaal van 6.427. 279,63 EUR te brengen op 28.616.682,67 EUR. De vergadering beslist dat deze kapitaalverhoging zal verwezenlijkt worden door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}17-06-2025 Kapitaalverhoging van €2.500.000 tot €5.406.044,43
- €2.906.044,43 → €5.406.044,43
- 4 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1000114.9,
"currency": "EUR",
"after_eur": 2906044.43,
"delta_eur": 1000114.9,
"before_eur": 1905929.53,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-23",
"evidence_quote": "Ingevolgde de huidige uitoefening van inschrijvingsrechten wordt het kapitaal van de voormelde vennootschap \u201CAPIX Biosciences\u201D verhoogd met een bedrag van 1.000.114,90 EUR, gepaard gaande met een uitgifte van 10.344 Preferente Aandelen en 1.149 Aandelen B, die allen volledig zijn volgestort, ten bewijze waarvan een attest werd overhandigd uitgaande van ING bank de dato 23 mei 2025. Zodoende wordt het kapitaal van de vennootschap gebracht van 1.905.929,53 EUR op 2.906.044,43 EUR",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 2500000.0,
"currency": "EUR",
"after_eur": 5406044.43,
"delta_eur": 2500000.0,
"before_eur": 2906044.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-27",
"evidence_quote": "De vergadering beslist vervolgens een kapitaalverhoging door te voeren ten bedrage van 2.500.000,00 EUR om het kapitaal te brengen van 2.906.044,43 EUR op 5.406.044,43 EUR door de in onderhavige akte beschreven inbreng in natura (schuldvordering onder de vorm van een converteerbare lening de dato 19 december 2023)... De vergadering stelt vast en verzoekt ons, notaris, akte te nemen van het feit dat de voormelde kapitaalverhoging van 2.500.000,00 EUR daadwerkelijk verwezenlijkt werd en dat het kapitaal aldus daadwerkelijk gebracht werd van 2.906.044,43 EUR op 5.406.044,43 EUR",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 21235.2,
"currency": "EUR",
"after_eur": 5427279.63,
"delta_eur": 21235.2,
"before_eur": 5406044.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-23",
"evidence_quote": "Ingevolgde de huidige uitoefening van inschrijvingsrechten wordt het kapitaal van de voormelde vennootschap \u201CAPIX Biosciences\u201D verhoogd met een bedrag van 21.235,20 EUR, gepaard gaande met een uitgifte van 316 Aandelen B, die allen volledig zijn volgestort, ten bewijze waarvan een attest werd overhandigd uitgaande van ING bank de dato 23 mei 2025... Zodoende wordt het kapitaal van de vennootschap gebracht van 5.406.044,43 EUR op 5.427.279,63 EUR",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 1000000.0,
"currency": "EUR",
"after_eur": 6427279.63,
"delta_eur": 1000000.0,
"before_eur": 5427279.63,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-27",
"evidence_quote": "De vergadering beslist vervolgens een kapitaalverhoging door te voeren ten bedrage van 1.000.000,00 EUR om het kapitaal te brengen van 5.427.279,63 EUR op 6.427.279,63 EUR door de in onderhavige akte beschreven inbreng in natura (schuldvordering onder de vorm van een converteerbare lening de dato 3 februari 2025)... De vergadering stelt vast en verzoekt ons, notaris, akte te nemen van het feit dat de voormelde kapitaalverhoging van 1.000.000,00 EUR daadwerkelijk verwezenlijkt werd en dat het kapitaal aldus daadwerkelijk gebracht werd van 5.427.279,63 EUR op 6.427.279,63 EUR",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}17-06-2025 Kapitaalverhoging van €2.500.000 tot €5.406.044,43
- €2.906.044,43 → €5.406.044,43
- 4 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 2906044.43,
"delta_eur": 1000114.9,
"before_eur": 1905929.53,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "MELLONA",
"share_class": "Preferente",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 10344,
"contribution_amount_eur": 1000000.0
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Jan BOGAERT",
"share_class": "B",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 1149,
"contribution_amount_eur": 114.9
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Preferente",
"n_new_shares": 11494,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 96.67
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 1000114.9,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 5406044.43,
"delta_eur": 2500000.0,
"before_eur": 2906044.43,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "MELLONA",
"share_class": "Preferente",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 2848,
"contribution_amount_eur": 2500000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Preferente",
"n_new_shares": 2848,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 2500000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 2848,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 5427279.63,
"delta_eur": 21235.2,
"before_eur": 5406044.43,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Jan BOGAERT",
"share_class": "B",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 316,
"contribution_amount_eur": 21235.2
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "B",
"n_new_shares": 316,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.1
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 21235.2,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 6427279.63,
"delta_eur": 1000000.0,
"before_eur": 5427279.63,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "MELLONA",
"share_class": "Preferente",
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 732,
"contribution_amount_eur": 1000000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Preferente",
"n_new_shares": 732,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 1000000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 732,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Benedikt DEBERDT",
"firm_city": null,
"firm_name": "Notaris Benedikt DEBERDT",
"office_city": "Tielt",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-06-17",
"filing_date": "2025-06-13",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-05-27",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "BV BOES \u0026 VERRUE BEDRIJFSREVISOREN",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Mathias Verrue"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition van het proces-verbaal",
"verslag van de raad van bestuur",
"verslag van de revisor",
"co\u00F6rdinatie van de statuten"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "MELLONA",
"role": null,
"n_shares": 13884,
"share_class": "Preferente"
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Jan BOGAERT",
"role": null,
"n_shares": 1465,
"share_class": "B"
}
],
"share_classes_after": [
{
"n_shares": 14626,
"class_name": "Preferente",
"capital_share_eur": null,
"voting_rights_per_share": 3.0
},
{
"n_shares": 33449,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}09-04-2024 1 bestuurder benoemd, 1 ontslagnemend
- Jeremy Barnes — Bestuurder
- Geraldine Wright — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Geraldine Wright",
"address": "35 Henley Street, Oxford OX1 3SZ, UK",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "voluntary",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2023-11-24",
"evidence_quote": "Het vrijwillig ontslag van mevrouw Geraldine Wright, wonende te 35 Henley Street, Oxford OX1 3SZ, UK, als bestuurder met ingang van 24/11/2023.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeremy Barnes",
"address": "Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2023-12-19",
"evidence_quote": "de heer Jeremy Barnes, wonende te Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2027-07-22"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": {
"rrn": null,
"name": "Thierry Bogaert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "de heer Thierry Bogaert;",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": {
"rrn": null,
"name": "Sharon Shafir",
"address": null,
"birth_date": null,
"profession": "Prof.",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Prof. Sharon Shafir;",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": {
"rrn": null,
"name": "Tina Rogge",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "mevrouw Tina Rogge;",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Myrmex BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "BV Myrmex, met als vaste vertegenwoordiger de heer Jan Bogaert;",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": {
"rrn": null,
"name": "Jeremy Barnes",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "de heer Jeremy Barnes.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Luik",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2023-12-18",
"act_kind_objet": "ONTSLAG EN BENOEMING"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2023-12-18",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES NV",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Myrmex BV",
"person_name": null,
"org_rep_person_name": "Jan Bogaert",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}09-04-2024 1 bestuurder benoemd, 1 ontslagnemend
- Jeremy Barnes — Bestuurder
- Geraldine Wright — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Geraldine Wright",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-24",
"evidence_quote": "Het vrijwillig ontslag van mevrouw Geraldine Wright, wonende te 35 Henley Street, Oxford OX1 3SZ, UK, als bestuurder met ingang van 24/11/2023."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeremy Barnes",
"address": null,
"birth_date": null
},
"effective_date": "2023-12-19",
"evidence_quote": "De aandeelhouders besluiten met meerderheid van stemmen om, de hiernavolgende persoon te benoemen tot bestuurder van de vennootschap, met ingang van 19 december 2023 en dit tot 22 juli 2027: - de heer Jeremy Barnes, wonende te Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}23-01-2024 Statutenwijziging — vertaling van de statuten en coördinatie van de statuten
Technische details
{
"notary": {
"name": "Benedikt DEBERDT",
"firm_city": null,
"firm_name": "Notaris Benedikt DEBERDT",
"office_city": "Tielt",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-23",
"filing_date": "2024-01-19",
"act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-18",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"other"
],
"scope": null,
"trigger": null,
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.667.563",
"name_full_after": "APIX Biosciences",
"legal_form_after": "Naamloze vennootschap",
"name_full_before": "APIX Biosciences",
"current_zetel_raw": "Blauwhuisstraat 11 8750 Wingene",
"legal_form_before": "Naamloze vennootschap"
},
"special_mandates": [],
"articles_modified": [],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Benedikt DEBERDT",
"org_rep_person_name": null
},
"co_filed_documents": [
"een uitgifte van de akte",
"volmachten",
"verslag van het bestuursorgaan",
"verslag van de revisor",
"de geco\u00F6rdineerde tekst van de statuten"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"share_class_creation",
"capital_increase_cash"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 1260,
"label": "inschrijvingsrechten G",
"rights_summary": "Geeft houders van Aandelen B het recht (doch niet de plicht) om in te schrijven op Aandelen B na conversie van een converteerbare lening.",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}23-01-2024 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2023-12-18",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}07-09-2022 Kapitaalverhoging van €700.115,80 tot €1.905.929,53
- €1.205.813,73 → €1.905.929,53
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 700115.8,
"currency": "EUR",
"after_eur": 1905929.53,
"delta_eur": 700115.8,
"before_eur": 1205813.73,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-08-23",
"evidence_quote": "KAPITAALVERHOGING Ingevolgde de huidige uitoefening van inschrijvingsrechten wordt het kapitaal van de voormelde vennootschap \u201CAPIX Biosciences\u201D verhoogd met een bedrag van zevenhonderdduizend honderdvijftien euro tachtig cent (700.115,80 EUR) ... Het kapitaal bedraagt \u00E9\u00E9n miljoen negenhonderdenvijfduizend negenhonderdnegenentwintig euro drie\u00EBnvijftig cent (1.905.929,53 EUR).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}07-09-2022 Kapitaalverhoging van €700.115,80 tot €2.606.045,33
- €1.905.929,53 → €2.606.045,33
Technische details
{
"events": [
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0771.404.277",
"rrn": null,
"kind": "org",
"name": "MELLONA",
"share_class": "preferente",
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 10417,
"contribution_amount_eur": 700000.0
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "BOGAERT Jan",
"share_class": "B",
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 1158,
"contribution_amount_eur": 115.8
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "preferente",
"n_new_shares": 10417,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 67.2
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 2606045.33,
"delta_eur": 700115.8,
"before_eur": 1905929.53,
"subscribers": [
{
"kbo": "0771.404.277",
"rrn": null,
"kind": "org",
"name": "MELLONA",
"share_class": "preferente",
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 10417,
"contribution_amount_eur": 700000.0
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "BOGAERT Jan",
"share_class": "B",
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 1158,
"contribution_amount_eur": 115.8
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "preferente",
"n_new_shares": 10417,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 67.2
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Benedikt DEBERDT",
"firm_city": null,
"firm_name": "Notaris Benedikt DEBERDT",
"office_city": "Tielt",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-09-07",
"filing_date": "2022-09-05",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2022-08-23",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2022-08-18"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition van de akte en co\u00F6rdinatie van de statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 10417,
"class_name": "preferente",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 1158,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}21-06-2022 2 bestuurders benoemd, 2 ontslagnemend
- Jan Bogaert — Bestuurder
- Jan Bogaert — Gedelegeerd bestuurder
- Jan Bogaert — Bestuurder
- Jan Bogaert — Gedelegeerd bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De aandeelhouders besluiten unaniem om, met ingang vanaf de datum van onderhavige schriftelijke besluiten, het mandaat van de hiernavolgende bestuurder te herroepen: - de heer Jan Bogaert, met woonplaats te 8750 Wingene, Blauwhuisstraat 11."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0773713570",
"name": "BV Myrmex",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De aandeelhouders besluiten unaniem om, met ingang vanaf de datum van onderhavige schriftelijke besluiten tot 22 juli 2027, de hiernavolgende persoon te benoemen tot bestuurder van de vennootschap: - BV Myrmex, een besloten vennootschap naar Belgisch recht, met maatschappelijk zetel te 8750 Wingene,"
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De raad van bestuur besluit met unanimiteit om, met ingang vanaf de datum van onderhavige schriftelijke besluiten, het mandaat van de hiernavolgende gedelegeerd bestuurder te herroepen: -de heer Jan Bogaert, met woonplaats te 8750 Wingene, Blauwhuisstraat 11."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0773713570",
"name": "BV Myrmex",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De raad van bestuur besluit met unanimiteit, met ingang vanaf de datum van onderhavige schriftelijke besluiten, de hiernavolgende persoon te benoemen tot gedelegeerd bestuurder van de vennootscha\u0440: -BV MYRMEX, een besloten vennootschap naar Belgisch recht, met maatschappelijk zetel te 8750 Wingene, "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}01-09-2021 Kapitaalverhoging van €1.144.313,73 tot €1.205.813,73
- €61.500 → €1.205.813,73
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1144313.73,
"currency": "EUR",
"after_eur": 1205813.73,
"delta_eur": 1144313.73,
"before_eur": 61500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2021-08-18",
"evidence_quote": "De vergadering beslist een kapitaalverhoging door te voeren ten bedrage van \u00E9\u00E9n miljoen honderdvierenveertigduizend driehonderd dertien euro drie\u00EBnzeventig cent (1.144.313,73 EUR), om het kapitaal van \u00E9\u00E9nenzestigduizend vijfhonderd euro (61.500,00 EUR) te brengen op \u00E9\u00E9n miljoen tweehonderdenvijfduizend achthonderd dertien euro drie\u00EBnzeventig cent (1.205.813,73 EUR).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}01-09-2021 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2021-08-18",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}27-07-2021 Oprichting van een NV
Technische details
{
"kind": "oprichting",
"seat": "Blauwhuisstraat 11, 8750 Wingene",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1971-12-21",
"name": "Prof. WRIGHT Geraldine Ann",
"niss": null,
"address": "35 Henley Street, Oxford OX1 3SZ, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 17859.97,
"holder_person_name": "Prof. WRIGHT Geraldine Ann",
"is_subscriber_only": false,
"n_shares_subscribed": 800,
"amount_subscribed_eur": 17859.97,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1962-04-08",
"name": "Prof. SHAFIR Sharon Iechiel",
"niss": null,
"address": "70A Kazenelson Street, Nes Ziona, 7403950, Isra\u00EBl"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 16632.09,
"holder_person_name": "Prof. SHAFIR Sharon Iechiel",
"is_subscriber_only": false,
"n_shares_subscribed": 745,
"amount_subscribed_eur": 16632.09,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1960-05-27",
"name": "Prof. BARNES Jeremy David",
"niss": null,
"address": "Erinvore, Torrisdale, Campbeltown, Argyll PA28 6QT, Schotland"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 17859.97,
"holder_person_name": "Prof. BARNES Jeremy David",
"is_subscriber_only": false,
"n_shares_subscribed": 800,
"amount_subscribed_eur": 17859.97,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1989-01-05",
"name": "Dr. STABLER Daniel",
"niss": null,
"address": "3 Pipley Furlong, Oxford, OX4 4JW, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2678.99,
"holder_person_name": "Dr. STABLER Daniel",
"is_subscriber_only": false,
"n_shares_subscribed": 120,
"amount_subscribed_eur": 2678.99,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1986-08-15",
"name": "Dr. TEIXEIRA DE SOUSA Raquel",
"niss": null,
"address": "345 Marston Road OX3 OEP, Oxford, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2678.99,
"holder_person_name": "Dr. TEIXEIRA DE SOUSA Raquel",
"is_subscriber_only": false,
"n_shares_subscribed": 120,
"amount_subscribed_eur": 2678.99,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1986-12-08",
"name": "De heer DA SILVA GON\u00C7ALVES Rui Fernando",
"niss": null,
"address": "345 Marston Road OX3 OEP, Oxford, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2678.99,
"holder_person_name": "De heer DA SILVA GON\u00C7ALVES Rui Fernando",
"is_subscriber_only": true,
"n_shares_subscribed": 120,
"amount_subscribed_eur": 2678.99,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1992-05-18",
"name": "De heer BOGAERT Jan David",
"niss": null,
"address": "Blauwhuisstraat 11, 8750 Wingene, Belgi\u00EB"
},
"share_class": "B",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1111.0,
"holder_person_name": "De heer BOGAERT Jan David",
"is_subscriber_only": true,
"n_shares_subscribed": 1111,
"amount_subscribed_eur": 1111.0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 61500.0,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2021-07-22",
"post_incorporation_mandates": []
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | APIX Biosciences |